Jiangsu Hengrui Medicine Co., Ltd.
600276
Rang in aandelen
#544
Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged... Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged in the full spectrum of pharmaceutical operations, from the initial discovery and development of medications to their manufacturing and worldwide distribution. The company is actively advancing a substantial pipeline of drug candidates, which includes Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR-1702, and SHR-A1403. These prospective treatments are aimed at a diverse range of medical conditions, primarily focusing on oncology, metabolic disorders, pain management, and autoimmune diseases, among others. The enterprise was founded in 1970 and maintains its corporate headquarters in Lianyungang, China.
Aandeelprijs
$6.89
Marktkapitalisatie
$43.94B
Verandering (1 dag)
-2.91%
Verandering (1 jaar)
-24.78%
Land
CN
Handel Jiangsu Hengrui Medicine Co., Ltd. (600276)
Categorie
Healthcare
Aandelsplitsingen voor Jiangsu Hengrui Medicine Co., Ltd. (600276)
Het aandeel Jiangsu Hengrui Medicine Co., Ltd. (symbool: 600276) heeft in totaal 19 splitsingen ondergaan.
De meest recente splitsing vond plaats op Jun 10, 2021.
Eén aandeel 600276 dat vóór May 11, 2001 werd gekocht, staat nu gelijk aan 47.810942329106 aandelen 600276.
De meest recente splitsing vond plaats op Jun 10, 2021.
Eén aandeel 600276 dat vóór May 11, 2001 werd gekocht, staat nu gelijk aan 47.810942329106 aandelen 600276.
Lijst van aandelen splitsingen
| Jaar | Splitsing | Vermenigvuldiging | Cumulatieve vermenigvuldiging |
|---|---|---|---|
| 2021-06-10 | 6:5 | x1.2 | x47.810942329106 |
| 2020-05-25 | 6:5 | x1.2 | x39.842451940921 |
| 2019-03-28 | 6:5 | x1.2 | x33.202043284101 |
| 2018-05-30 | 13:10 | x1.3 | x27.668369403418 |
| 2017-05-31 | 6:5 | x1.2 | x21.283361079552 |
| 2016-06-16 | 6:5 | x1.2 | x17.73613423296 |
| 2015-06-15 | 13:10 | x1.3 | x14.7801118608 |
| 2014-05-15 | 11:10 | x1.1 | x11.369316816 |
| 2013-06-07 | 11:10 | x1.1 | x10.33574256 |
| 2012-05-29 | 11:10 | x1.1 | x9.3961296 |
| 2011-04-26 | 3:2 | x1.5 | x8.541936 |
| 2010-03-17 | 6:5 | x1.2 | x5.694624 |
| 2009-04-30 | 6:5 | x1.2 | x4.74552 |
| 2008-04-11 | 6:5 | x1.2 | x3.9546 |
| 2007-04-02 | 13:10 | x1.3 | x3.2955 |
| 2006-08-29 | 13:10 | x1.3 | x2.535 |
| 2006-06-19 | 5:4 | x1.25 | x1.95 |
| 2002-05-21 | 6:5 | x1.2 | x1.56 |
| 2001-05-11 | 13:10 | x1.3 | x1.3 |
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
| Bedrijf | Aantal aandelen splitsingen | Cumulatieve vermenigvuldiging | Land |
|---|---|---|---|
| 0 | - |
DE
|
|
| 0 | - |
DE
|
|
| 0 | - |
JP
|
|
| 0 | - |
CH
|
|
| 5 | x119 |
IN
|
